Replimune
Price & Volume
Stats
See moreOpen | $3.78 |
Previous Close | $3.74 |
Day Range | $3.74-$4.11 |
52W Range | $1.50-$13.24 |
Market Cap | $336M |
Shares Short | 18M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.44 |
News
See moreYahoo Finance • 25 days ago
Jefferies Sees Reduced Visibility for Replimune Group, Inc. (REPL) Following FDA Decision
Yahoo Finance • 29 days ago
Street sours on Replimune as stock hits all-time low on melanoma drug rejection
Yahoo Finance • 29 days ago
Replimune Group, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
Yahoo Finance • 29 days ago
Replimune shares extend losses, tumble 56% after FDA rejects melanoma drug RP1
About
CEO | Dr. Sushil Patel Ph.D. |
Address | 500 Unicorn Park Drive, Woburn, MA, United States, 01801 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 479 |